Rheumatic syndromes and occult tumor: 10-Year experience in a teaching hospital David Castro Corredor; Marco Aurelio Ramírez Huaranga; Ana Isabel Rebollo Giménez; Rocío Arenal López; José Luis Cuadra Díaz;

Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients Vicenç Torrente-Segarra; Manuel Fernández Prada; Rosa Expósito; Noemí Patricia Garrido Puñal; Amalia Sánchez-Andrade; José Ramón Lamúa-Riazuelo; Alejandro Olivé; Juan Víctor Tovar;